igf-1 lr3 long term use IGF1-LR3 Peptide IGF-1 LR3 Peptide Therapy in

The optimal choice depends on whether the focus is hypertrophy signaling or recovery enhancement

Research shows that it stimulates growth hormone release without significantly influencing levels of ACTH, prolactin, FSH, LH, TSH, or cortisol

Dosage and Protocols of CJC-1295 and Ipamorelin In human trials 5 , single subcutaneous injections of CJC-1295 at ~ 30-60 g/kg produced dose-dependent increases in GH and IGF-1 for 69 days post-dose

For teams working on selective signaling projects, Ipamorelin 10mg offers a practical size for pathway mapping, controlled analytical review, and documented lab use without adding unnecessary complexity